pharma · Non-muscle invasive bladder cancer (NMIBC) · Low Grade Upper Tract Urothelial Carcinoma · TYRA
Tyra Biosciences
Tyra Biosciences clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Carlsbad, USA HQ
93 Employees
Public company Type
TYRA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Carlsbad, USA
- Employees
- 93
- Programs
- 9
- Drugs
- 3
- Patents
- 17
Tyra Biosciences projects
0 ClinicalTrials.gov programs sponsored by Tyra Biosciences.
Tyra Biosciences has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Tyra Biosciences have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.